1872 related articles for article (PubMed ID: 8440914)
21. Nerve growth and expression of receptors for nerve growth factor in tumors of melanocyte origin.
Bröcker EB; Magiera H; Herlyn M
J Invest Dermatol; 1991 May; 96(5):662-5. PubMed ID: 1850772
[TBL] [Abstract][Full Text] [Related]
22. Common acquired melanocytic nevi, dysplastic melanocytic nevi and malignant melanomas: an image analysis cytometric study.
Bruijn JA; Berwick M; Mihm MC; Barnhill RL
J Cutan Pathol; 1993 Apr; 20(2):121-5. PubMed ID: 8320355
[TBL] [Abstract][Full Text] [Related]
23. Dysplastic nevi in relation to superficial spreading melanoma.
Titus-Ernstoff L; Barnhill RL; Duray PH; Ernstoff MS; Kirkwood JM
Cancer Epidemiol Biomarkers Prev; 1993; 2(2):99-101. PubMed ID: 8467253
[TBL] [Abstract][Full Text] [Related]
24. The initial steps of tumor progression in melanocytic lineage: a histochemical approach.
Wollina U; Kilian U; Henkel U; Schaarschmidt H; Knopf B
Anticancer Res; 1991; 11(4):1405-14. PubMed ID: 1746897
[TBL] [Abstract][Full Text] [Related]
25. Actin-binding protein expression in benign and malignant melanocytic proliferations.
Bouffard D; Duncan LM; Howard CA; Mihm MC; Byers HR
Hum Pathol; 1994 Jul; 25(7):709-14. PubMed ID: 8026830
[TBL] [Abstract][Full Text] [Related]
26. Acral melanocytic neoplasms: a histologic analysis of 158 lesions.
Boyd AS; Rapini RP
J Am Acad Dermatol; 1994 Nov; 31(5 Pt 1):740-5. PubMed ID: 7929919
[TBL] [Abstract][Full Text] [Related]
27. Different patterns of expression of the erbB family of receptor tyrosine kinases in common nevi, dysplastic nevi, and primary malignant melanomas: an immunohistochemical study.
Feinmesser M; Veltman V; Morgenstern S; Tobar A; Gutman H; Kaganovsky E; Tzabari C; Sulkes J; Okon E
Am J Dermatopathol; 2010 Oct; 32(7):665-75. PubMed ID: 20559114
[TBL] [Abstract][Full Text] [Related]
28. Biological behaviour of cutaneous malignant melanomas.
Søndergaard K
Pathology; 1985 Apr; 17(2):255-7. PubMed ID: 4047727
[TBL] [Abstract][Full Text] [Related]
29. Loss of expression of protein kinase a regulatory subunit 1alpha in pigmented epithelioid melanocytoma but not in melanoma or other melanocytic lesions.
Zembowicz A; Knoepp SM; Bei T; Stergiopoulos S; Eng C; Mihm MC; Stratakis CA
Am J Surg Pathol; 2007 Nov; 31(11):1764-75. PubMed ID: 18059235
[TBL] [Abstract][Full Text] [Related]
30. Comparison of pHH3, Ki-67, and survivin immunoreactivity in benign and malignant melanocytic lesions.
Nasr MR; El-Zammar O
Am J Dermatopathol; 2008 Apr; 30(2):117-22. PubMed ID: 18360113
[TBL] [Abstract][Full Text] [Related]
31. Nevoid melanoma: a clinicopathological study of seven cases of malignant melanoma mimicking spindle and epithelioid cell nevus and verrucous dermal nevus.
Wong TY; Suster S; Duncan LM; Mihm MC
Hum Pathol; 1995 Feb; 26(2):171-9. PubMed ID: 7860047
[TBL] [Abstract][Full Text] [Related]
32. Immunohistochemical expression of cyclooxygenase-2 (COX-2) in oral nevi and melanoma.
de Souza do Nascimento J; Carlos R; Delgado-Azañero W; Mosqueda Taylor A; de Almeida OP; Romañach MJ; de Andrade BA
J Oral Pathol Med; 2016 Jul; 45(6):440-3. PubMed ID: 26608958
[TBL] [Abstract][Full Text] [Related]
33. Pagetoid melanocytosis. Histologic features in benign and malignant lesions.
Haupt HM; Stern JB
Am J Surg Pathol; 1995 Jul; 19(7):792-7. PubMed ID: 7793477
[TBL] [Abstract][Full Text] [Related]
34. [Epiluminescence microscopic characteristics of small malignant melanoma].
Schulz H
Hautarzt; 1997 Dec; 48(12):904-9. PubMed ID: 9486362
[TBL] [Abstract][Full Text] [Related]
35. Black and Brown Oro-facial Mucocutaneous Neoplasms.
Natarajan E
Head Neck Pathol; 2019 Mar; 13(1):56-70. PubMed ID: 30693458
[TBL] [Abstract][Full Text] [Related]
36. Residual dysplastic and other nevi in superficial spreading melanoma. Clinical correlations and association with sun damage.
Black WC
Cancer; 1988 Jul; 62(1):163-73. PubMed ID: 3383113
[TBL] [Abstract][Full Text] [Related]
37. Small congenital nevi associated with melanoma: case reports and considerations.
Betti R; Inselvini E; Vergani R; Crosti C
J Dermatol; 2000 Sep; 27(9):583-90. PubMed ID: 11052234
[TBL] [Abstract][Full Text] [Related]
38. The Complex Interplay between Nevi and Melanoma: Risk Factors and Precursors.
Shreberk-Hassidim R; Ostrowski SM; Fisher DE
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834954
[TBL] [Abstract][Full Text] [Related]
39. Association of Patient Risk Factors and Frequency of Nevus-Associated Cutaneous Melanomas.
Haenssle HA; Mograby N; Ngassa A; Buhl T; Emmert S; Schön MP; Rosenberger A; Bertsch HP
JAMA Dermatol; 2016 Mar; 152(3):291-8. PubMed ID: 26536613
[TBL] [Abstract][Full Text] [Related]
40. Favorable prognosis for malignant melanomas associated with acquired melanocytic nevi.
Friedman RJ; Rigel DS; Kopf AW; Lieblich L; Lew R; Harris MN; Roses DF; Gumport SL; Ragaz A; Waldo E; Levine J; Levenstein M; Koenig R; Bart RS; Trau H
Arch Dermatol; 1983 Jun; 119(6):455-62. PubMed ID: 6859885
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
